The US FDA has granted accelerated approval to atrasentan (Vanrafia) for reducing proteinuria in adults with primary ...

Glomerular disease affects the Glomeruli and ... They excrete waste and excess fluid into the urine while holding back the protein and blood products that your body needs.” ...

IgAN is a progressive, rare kidney disease in which the immune system attacks the kidneys, often causing glomerular ...

The identification of the glomeruli as the source of bleeding is important. Patients with clear evidence of glomerular hematuria do not need to be evaluated for potentially serious urologic disease.

Increased risk of sudden cardiac arrest in younger adults with proteinuria was higher in those with chronic kidney disease. Proteinuria is associated with higher risk of sudden cardiac arrest in ...

Persistent proteinuria can cause kidney failure within ... Nephrology; director of the Glomerular Disease Center at Stanford University Medical Center; and Vanrafia ALIGN study investigator ...

Unlocking the novel functions of the ADGRF5 receptor holds promise for pioneering therapeutic breakthroughs in treating ...

Novartis has received accelerated approval from the US Food and Drug Administration (FDA) for Vanrafia (atrasentan), a potent ...

Male pups were given either a normal-protein (NP) diet (LP/NP) or HP diet (LP/HP), and normal male pups as control (NP/NP). At 12 wk, LP/HP offspring displayed no increase in glomerular number but ...